Therapeutic Apheresis in Children: Special Considerations

Seminars in Dialysis

Volumn 25, Issue 2, 2012, Pages 165-170

  Goldstein, Stuart L ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISSEMINATED ENCEPHALOMYELITIS; AGE; APHERESIS; ARTICLE; CHILD; CRITICAL ILLNESS; FEMALE; GUILLAIN BARRE SYNDROME; HOSPITAL; HUMAN; KIDNEY DISEASE; MALE; METHODOLOGY; MORTALITY; MULTIPLE ORGAN FAILURE; PATIENT SAFETY; PATIENT SELECTION; PEDIATRICS; PRESCHOOL CHILD; PROGNOSIS; RISK ASSESSMENT; SEPSIS; SURVIVAL RATE; TREATMENT OUTCOME;

AGE FACTORS; BLOOD COMPONENT REMOVAL; CHILD; CHILD, PRESCHOOL; CRITICAL ILLNESS; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; FEMALE; GUILLAIN-BARRE SYNDROME; HOSPITALS, PEDIATRIC; HUMANS; KIDNEY DISEASES; MALE; MULTIPLE ORGAN FAILURE; PATIENT SAFETY; PATIENT SELECTION; PEDIATRICS; PROGNOSIS; RISK ASSESSMENT; SEPSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84858698479     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2011.01028.x     Document Type: Article

References (59)

1. Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Weinstein R, Shaz BH: Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 25:83-177, 2010
2. Akcan-Arikan A, Zappitelli M, Loftis LL, Washburn KK, Jefferson LS, Goldstein SL: Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int 71:1028-1035, 2007
3. Proulx F, Fayon M, Farrell CA, Lacroix J, Gauthier M: Epidemiology of sepsis and multiple organ dysfunction syndrome in children. Chest 109:1033-1037, 1996
4. Proulx F, Gauthier M, Nadeau D, Lacroix J, Farrell CA: Timing and predictors of death in pediatric patients with multiple organ system failure. Crit Care Med 22:1025-1031, 1994
5. Bunchman TE: Plasmapheresis and renal replacement therapy in children. Curr Opin Pediatr 14:310-314, 2002
6. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA: Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 325:393-397, 1991
7. Caprioli J, Noris M, Brioschi S, Pianetti G, Castelletti F, Bettinaglio P, Mele C, Bresin E, Cassis L, Gamba S, Porrati F, Bucchioni S, Monteferrante G, Fang CJ, Liszewski MK, Kavanagh D, Atkinson JP, Remuzzi G: Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood 108:1267-1279, 2006
8. Ariceta G, Besbas N, Johnson S, Karpman D, Landau D, Licht C, Loirat C, Pecoraro C, Taylor CM, Van de Kar N, Vandewalle J, Zimmerhackl LB: Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatr Nephrol 24:687-696, 2009
9. Zimmerhackl LB, Besbas N, Jungraithmayr T, van de Kar N, Karch H, Karpman D, Landau D, Loirat C, Proesmans W, Prufer F, Rizzoni G, Taylor MC: Epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome. Semin Thromb Hemost 32:113-120, 2006
10. Levy JB, Turner AN, Rees AJ, Pusey CD: Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 134:1033-1042, 2001
11. Simpson IJ, Doak PB, Williams LC, Blacklock HA, Hill RS, Teague CA, Herdson PB, Wilson CB: Plasma exchange in Goodpasture's syndrome. Am J Nephrol 2:301-311, 1982
12. de Lind van Wijngaarden RA, Hauer HA, Wolterbeek R, Jayne DR, Gaskin G, Rasmussen N, Noel LH, Ferrario F, Waldherr R, Hagen EC, Bruijn JA, Bajema IM: Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: a prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol 17:2264-2274, 2006
13. Stegmayr BG, Almroth G, Berlin G, Fehrman I, Kurkus J, Norda R, Olander R, Sterner G, Thysell H, Wikstrom B, Wiren JE: Plasma exchange or immunoadsorption in patients with rapidly progressive crescentic glomerulonephritis. A Swedish multi-center study. Int J Artif Organs 22:81-87, 1999
14. Bambauer R, Schwarze U, Schiel R: Cyclosporin A and therapeutic plasma exchange in the treatment of severe systemic lupus erythematosus. Artif Organs 24:852-856, 2000
15. Neuwelt CM: The role of plasmapheresis in the treatment of severe central nervous system neuropsychiatric systemic lupus erythematosus. Ther Apher Dial 7:173-182, 2003
16. Lewis EJ, Hunsicker LG, Lan SP, Rohde RD, Lachin JM: A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. N Engl J Med 326:1373-1379, 1992
17. Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK, Ellis E, Lovell H, Warady B, Gunwar S, Chonko AM, Artero M, Vincenti F: Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 334:878-883, 1996
18. Davenport RD: Apheresis treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation: re-analysis of published case-reports and case-series. J Clin Apher 16:175-178, 2001
19. Loupy A, Suberbielle-Boissel C, Zuber J, Anglicheau D, Timsit MO, Martinez F, Thervet E, Bruneval P, Charron D, Hill GS, Nochy D, Legendre C: Combined posttransplant prophylactic IVIg/anti-CD 20/plasmapheresis in kidney recipients with preformed donor-specific antibodies: a pilot study. Transplantation 89:1403-1410, 2010
20. Lefaucheur C, Nochy D, Andrade J, Verine J, Gautreau C, Charron D, Hill GS, Glotz D, Suberbielle-Boissel C: Comparison of combination plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection. Am J Transplant 9:1099-1107, 2009
21. Nguyen TC, Han YY, Kiss JE, Hall MW, Hassett AC, Jaffe R, Orr RA, Janosky J, Carcillo JA: Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure. Crit Care Med 36:2878-2887, 2008
22. Busund R, Koukline V, Utrobin U, Nedashkovsky E: Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial. Intensive Care Med 28:1434-1439, 2002
23. Velasquez MP, Mariscalco MM, Goldstein SL, Airewele GE: Erythrocytapheresis in children with sickle cell disease and acute chest syndrome. Pediatr Blood Cancer 53:1060-1063, 2009
24. Adams DM, Schultz WH, Ware RE, Kinney TR: Erythrocytapheresis can reduce iron overload and prevent the need for chelation therapy in chronically transfused pediatric patients. J Pediatr Hematol Oncol 18:46-50, 1996
25. Kim HC, Dugan NP, Silber JH, Martin MB, Schwartz E, Ohene-Frempong K, Cohen AR: Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease. Blood 83:1136-1142, 1994
26. Stemmler J, Wittmann GW, Hacker U, Heinemann V: Leukapheresis in chronic myelomonocytic leukemia with leukostasis syndrome: elevated serum lactate levels as an early sign of microcirculation failure. Leuk Lymphoma 43:1427-1430, 2002
27. Rowe JM, Lichtman MA: Hyperleukocytosis and leukostasis: common features of childhood chronic myelogenous leukemia. Blood 63:1230-1234, 1984
28. Maurer HS, Steinherz PG, Gaynon PS, Finklestein JZ, Sather HN, Reaman GH, Bleyer WA, Hammond GD: The effect of initial management of hyperleukocytosis on early complications and outcome of children with acute lymphoblastic leukemia. J Clin Oncol 6:1425-1432, 1988
29. Steeper TA, Smith JA, McCullough J: Therapeutic cytapheresis using the Fenwal CS-3000 blood cell separator. Vox Sang 48:193-200, 1985
30. Benito AI, Gonzalez-Vicent M, Garcia F, Balas A, Quintero V, Madero L, Vicario JL, Diaz MA: Allogeneic peripheral blood stem cell transplantation (PBSCT) from HLA-identical sibling donors in children with hematological diseases: a single center pilot study. Bone Marrow Transplant 28:537-543, 2001
31. Diaz MA, Garcia-Sanchez F, Lillo R, Vicent MG, Vicario JL, Madero L: Large-volume leukapheresis in pediatric patients: pre-apheresis peripheral blood CD34+ cell count predicts progenitor cell yield. Haematologica 84:32-35, 1999
32. Goldman JM, Horowitz MM: The international bone marrow transplant registry. Int J Hematol 76(Suppl 1):393-397, 2002
33. Gorlin JB, Humphreys D, Kent P, Galacki D, Kevy SV, Grupp S, Diller L, Weinstein H, Grier H, Shamberger R: Pediatric large volume peripheral blood progenitor cell collections from patients under 25kg: a primer. J Clin Apher 11:195-203, 1996
34. Marson P, Petris MG, Messina C, Cecchetto G, Giordano R, Zanesco L, De Silvestro G: [Peripheral blood stem cell collection in pediatric oncohematology. Experience with patients weighing less than 15kg]. Minerva Pediatr 52:129-135, 2000
35. Sevilla J, Gonzalez-Vicent M, Madero L, Diaz MA: Peripheral blood progenitor cell collection in low-weight children. J Hematother Stem Cell Res 11:633-642, 2002
36. Torrabadella M, Olive T, Ortega JJ, Massuet L: Enhanced HPC recruitment in children using LVL and a new automated apheresis system. Transfusion 40:404-410, 2000
37. Collins RH Jr, Shpilberg O, Drobyski WR, Porter DL, Giralt S, Champlin R, Goodman SA, Wolff SN, Hu W, Verfaillie C, List A, Dalton W, Ognoskie N, Chetrit A, Antin JH, Nemunaitis J: Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 15:433-444, 1997
38. Drobyski WR, Hessner MJ, Klein JP, Kabler-Babbitt C, Vesole DH, Margolis DA, Keever-Taylor CA: T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation. Blood 94:434-441, 1999
39. Drobyski WR, Keever CA, Roth MS, Kabler-Babbitt C, Vesole DH, Margolis DA, Keever-Taylor CA: Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose. Blood 82:2310-2318, 1993
40. Gasparetto C, Gasparetto M, Morse M, Rooney B, Vredenburgh JJ, Long GD, Rizzieri DA, Loftis J, Chao NJ, Smith C: Mobilization of dendritic cells from patients with breast cancer into peripheral blood stem cell leukapheresis samples using Flt-3-ligand and G-CSF or GM-CSF. Cytokine 18:8-19, 2002
41. Mandanas RA, Saez RA, Selby GB, Confer DL: G-CSF-mobilized donor leukocyte infusions as immunotherapy in acute leukemia relapsing after allogeneic marrow transplantation. J Hematother 7:449-456, 1998
42. Zic JA, Miller JL, Stricklin GP, King LE Jr: The North American experience with photopheresis. Ther Apher 3:50-62, 1999
43. Rook AH, Suchin KR, Kao DM, Yoo EK, Macey WH, DeNardo BJ, Bromely PG, Geng Y, Junkins-Hopkins JM, Lessin SR: Photopheresis: clinical applications and mechanism of action. J Investig Dermatol Symp Proc 4:85-90, 1999
44. Knobler R, Jantschitsch C: Extracorporeal photochemoimmunotherapy in cutaneous T-cell lymphoma. Transfus Apher Sci 28:81-89, 2003
45. Knobler R, Girardi M: Extracorporeal photochemoimmunotherapy in cutaneous T cell lymphomas. Ann N Y Acad Sci 941:123-138, 2001
46. Knobler R: Extracorporeal photochemotherapy - present and future. Vox Sang 78(Suppl 2):197-201, 2000
47. Greinix HT, Volc-Platzer B, Rabitsch W, Gmeinhart B, Guevara-Pineda C, Kalhs P, Krutmann J, Honigsmann H, Ciovica M, Knobler RM: Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood 92:3098-3104, 1998
48. Shinoda T: Photopheresis and leukocytapheresis: cytapheresis treatment against immune-mediated diseases. Ther Apher 6:245-246, 2002
49. Schneider M: [Plasma- and lymphapheresis in autoimmune diseases]. Z Rheumatol 55:90-104, 1996
50. Costanzo-Nordin MR, Hubbell EA, O'Sullivan EJ, Johnson MR, Mullen GM, Heroux AL, Kao WG, McManus BM, Pifarre R, Robinson JA: Photopheresis versus corticosteroids in the therapy of heart transplant rejection. Preliminary clinical report. Circulation 86:II242-II250, 1992
51. Meiser BM, Kur F, Reichenspurner H, Wagner F, Boos KS, Vielhauer S, Weiss M, Rohrbach H, Kreuzer E, Uberfuhr P, et al.: Reduction of the incidence of rejection by adjunct immunosuppression with photochemotherapy after heart transplantation. Transplantation 57:563-568, 1994
52. Rossetti F, Dall'Amico R, Crovetti G, Messina C, Montini G, Dini G, Locatelli F, Argiolu F, Miniero R, Zacchello G: Extracorporeal photochemotherapy for the treatment of graft-versus-host disease. Bone Marrow Transplant 18(Suppl 2):175-181, 1996
53. Dall'Amico R, Rossetti F, Zulian F, Montini G, Murer L, Andreetta B, Messina C, Baraldi E, Montesco MC, Dini G, Locatelli F, Argiolu F, Zacchello G: Photopheresis in paediatric patients with drug-resistant chronic graft-versus-host disease. Br J Haematol 97:848-854, 1997
54. Bunchman TE, Brophy PD, Goldstein SL: Technical considerations for renal replacement therapy in children. Semin Nephrol 28:488-492, 2008
55. Carausu L, Clapisson G, Philip I, Sebban H, Marec-Berard P: Use of totally implantable catheters for peripheral blood stem cell apheresis. Bone Marrow Transplant 40:417-422, 2007
56. Nadler S, Hidalgo J, Bloch T: Prediction of blood volume in normal human adults. Surgery 51:224-232, 1962
57. Bunchman TE, Maxvold NJ, Barnett J, Hutchings A, Benfield MR: Pediatric hemofiltration: normocarb dialysate solution with citrate anticoagulation. Pediatr Nephrol 17:150-154, 2002
58. Brophy PD, Somers MJ, Baum MA, Symons JM, McAfee N, Fortenberry JD, Rogers K, Barnett J, Blowey D, Baker C, Bunchman TE, Goldstein SL: Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT). Nephrol Dial Transplant 20:1416-1421, 2005
59. Michon B, Moghrabi A, Winikoff R, Barrette S, Bernstein ML, Champagne J, David M, Duval M, Hume HA, Robitaille N, Belisle A, Champagne MA: Complications of apheresis in children. Transfusion 47:1837-1842, 2007